Frontier Science & Technology Research Foundation, Inc.
Age
0–1
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Neonates born in New York State during cCMV NBS Pilot Program (September 27, 2023 - October 1, 2024)
cCMV evaluation provided by a designated NYS cCMV clinical referral site
Family willing and able to complete all study procedures
Study participants meet criteria for one of the following four categories:
1\. Category 1 (Confirmed cCMV identified by NBS Program): cCMV NYS newborn screen positive AND cCMV confirmatory test positive
2\. Category 2 (Confirmed cCMV not identified by NBS Program): cCMV NYS newborn screen negative AND cCMV confirmatory test positive
3\. Category 3 (False-positive cCMV screen): cCMV NYS newborn screen positive AND negative cCMV confirmatory test
4\. Category 4 (Premature infants with confirmed CMV infection on late positive NBS): Infant born prior to 37 weeks gestation AND cCMV positive on any NYS newborn screen collected prior to 44 weeks gestational age AND Positive cCMV confirmatory test obtained within 14 days of a positive NBS
You may not be if
Neonate whose parents refuse participation in the long-term follow-up study
Clareo Health | Long-Term Outcomes of Children With Congenital CMV in New York State
